Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Bolster Consumables Portfolio with Finnzymes Acquisition

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market Monday that it will acquire Finnzymes for an undisclosed sum.

Espoo, Finland-based Finnzymes makes reagents, consumables, kits, and instruments for molecular biology applications. Its proprietary DNA polymerases, called Phire and Phusion, and high-speed miniaturized thermal cyclers will expand Thermo Fisher's portfolio of reagents and other consumables for the molecular biology research and diagnostics markets.

"The addition of Finnzymes’ innovative enzyme portfolio and unique PCR instrument platform strengthens our broad range of life science reagents and consumables, as well as our specialty diagnostics product offering,” Marc Casper, president and CEO of Thermo Fisher, said in a statement.

Finnzymes employs 90 people and generated revenues of $20 million in 2009, according to Thermo Fisher. The acquired firm will be integrated into Thermo Fisher's Analytical Technologies Segment, with some equipment and consumables product lines being added to ita Laboratory Products and Services Segment.

The firms expect to close the deal during the first quarter of 2010. Thermo Fisher added that Finnzymes' operations are not expected to have a material impact on its 2010 financial results.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.